MedDataX Logo

Developement of Questionnaire to Evaluate a Regularity of Lifestyle in Type 2 Diabetic Patients

NCT ID: NCT00455988

Last Updated: 2007-04-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

360 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-09-30

Study Completion Date

2007-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In order to manage of type 2 diabetic patients with irregular lifestyle, developement of an appropriate questionnaire to evaluate a regularity of lifestyle is necessary.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We have a plan to perform the seven day's records and the questionnaires which is necessary to type 2 diabetic patients for the initial step. Next, we will revise a questionnaire with professional advices for several times. Finally we will test a reliability with a final version as form of multisite based study and will confirm a questionnaire for a regularity of lifestyle in type 2 diabetes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Type 2 diabetic patients

Exclusion Criteria

* Type 1 diabetic patients, gestational DM patients
Minimum Eligible Age

30 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Eulji University Hospital

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kyung Wan Min, MD., PhD

Role: PRINCIPAL_INVESTIGATOR

Eulji University Hospital Diabetes Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Eulji University Hospital

Seoul, , South Korea

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Song Yi Back

Role: CONTACT

[email protected]
82-2-970-8459

Ji Sun Min

Role: CONTACT

82-2-970-8459

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Song Yi Back

Role: primary

[email protected]
82-2-970-8459

Ji Sun Min

Role: backup

82-2-970-8459

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Questionnaire06-27-1

Identifier Type: -

Identifier Source: org_study_id